AASUR in High Risk Prostate Cancer
The purpose of this study is to determine whether anti-testosterone medications, when administered before, during, and after high-dose, precision radiation, will be effective in preventing the prostate cancer from returning.
Prostate Cancer
DRUG: ARN-509|DRUG: Abiraterone|DRUG: Leuprolide|RADIATION: stereotactic, ultra-fractionated radiotherapy
proportion of patients with biochemical failure, Biochemical failure is defined as an increase in PSA by more than 2ng/mL above the nadir value. PSA rise equals or exceeds 2ng/mL will be the date of failure., 36 months
The purpose of this study is to determine whether anti-testosterone medications, when administered before, during, and after high-dose, precision radiation, will be effective in preventing the prostate cancer from returning.